Advisory Research Inc Sarepta Therapeutics, Inc. Transaction History

Advisory Research Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $80,625 - $107,009	686 Added 25.0%	3,430 $472,000
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $276,759 - $362,564	2,744 New	2,744 $355,000
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $223,324 - $522,224	-3,091 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $187,712 - $267,216	1,495 Added 93.67%	3,091 $527,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $109,323 - $148,212	-860 Reduced 35.02%	1,596 $224,000
Q2 2020 Aug 13, 2020	BUY	$93.0 - $171.7 $228,408 - $421,695	2,456 New	2,456 $394,000
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $129,240 - $197,553	-1,328 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $153,131 - $214,485	1,328 New	1,328 $214,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.